Covid-19: At Rs 2,800 per dose, Zydus launches cheapest remdesivir brand

Zydus plans to supply large quantities of the injectable drug in the market soon

Disrupting the Covid drug market in the country, Cadila Healthcare (Zydus Cadila) on Thursday launched the cheapest remdesivir brand Remdac, priced at Rs2,800 per dose. The drug is 30 per cent cheaper than Cipla’s Cipremi, which was the cheapest remdesivir in the market till now.

This could also be the lowest priced brand of remdesivir globally. 

Gilead's drug is priced at $390 per vial (Rs29,000) for patients on government-sponsored insurance and $520 (Rs38,900) per vial for patients with private insurance. 

Zydus Cadila is the fifth company to have launched its generic version of remdesivir in India after Hetero Labs, Cipla, Mylan, and Jubilant